A traveling SARS-CoV-2 laboratory as part of a pandemic response among vulnerable Brazilian populations.

Maria Carolina EliasSvetoslav Nanev SlavovAlex Ranieri Jeronimo LimaAntonio Jorge MartinsClaudia Renata Dos Santos BarrosDebora Botequio MorettiEduardo L AraujoElaine Cristina MarquezeGabriela RibeiroGabriela Mauric Frossard RibeiroJardelina Souza Todao BernardinoJaqueline Reginato KoserLuan Gaspar ClementeLuiz Aurelio Campos CrispinLuiz Carlos Junior AlcantaraLuiz Lehmann CoutinhoMarta GiovanettiQuetura Oliveira SilvaRaul Machado NetoRicardo HaddadSimone KashimaVincent Louis VialaDimas Tadeu CovasSandra Coccuzzo Sampaio

Published in: BMC public health (2023)

The SARS-CoV-2 pandemic has demonstrated worldwide the importance of science to fight against this viral agent and the LabMovel shows that it is possible to integrate researchers, clinicians, healthcare workers and patients to take rapid actions that can in fact mitigate this and other epidemiological situations.

Keyphrases

sars cov
respiratory syndrome coronavirus
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
public health
palliative care
patient reported
quantum dots
genetic diversity